Edition:
United States

Natus Medical Inc (BABY.O)

BABY.O on Nasdaq

39.65USD
18 Oct 2017
Change (% chg)

$0.50 (+1.28%)
Prev Close
$39.15
Open
$39.30
Day's High
$39.80
Day's Low
$39.10
Volume
332,218
Avg. Vol
376,865
52-wk High
$43.85
52-wk Low
$31.65

Chart for

About

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $1,297.81
Shares Outstanding(Mil.): 33.15
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 162.13 16.86
EPS (TTM): -- -- --
ROI: -- 9.55 11.22
ROE: -- 14.91 15.09

BRIEF-Natus to acquire neurosurgery assets from Integra Lifesciences

* Natus to acquire neurosurgery assets from Integra Lifesciences, enters neurosurgery market

Sep 11 2017

BRIEF-Integra Lifesciences to sell neurosurgery assets to Natus Medical

* Integra Lifesciences announces definitive agreement to sell certain neurosurgery assets to Natus Medical Incorporated

Sep 11 2017

BRIEF-Natus Medical Q2 GAAP loss per share $0.15

* Natus Medical announces second quarter 2017 financial results

Jul 26 2017

BRIEF-Natus Medical CEO James Hawkins purchases 4000 shares of co's common stock - SEC Filing

* Natus medical inc ceo james hawkins reports purchase of 4000 shares of co's common stock on june 15 at $33.98 per share - sec filing Source text (http://bit.ly/2t6OYwA) Further company coverage:

Jun 15 2017

BRIEF-Natus Medical Q1 non-gaap earnings per share $0.30

* Natus medical announces first quarter 2017 financial results

Apr 26 2017

BRIEF-Natus Medical Q1 non-gaap EPS $0.30

* For q2 of 2017, company provided revenue guidance of $121.0 million to $123.0 million

Apr 26 2017

Earnings vs. Estimates